Skip to content
StockMarketAgent
Direct answer
NTES trades against a final fair-value range of $139.31-$218.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $139, high $219, with mid-point at $178.
Stock analysis

NTES fair value $139–$219

By StockMarketAgent.AI team· supervised by
Analisado: 2026-05-20Próxima atualização: 2026-08-20Methodology v2.4Data cut-off: Quality gate: passSources: all material sources passed deterministic freshness/provenance gatesReview: automatedArchetype: Mature compounder
View archive
Preço
$114.49
▲ +63.29 (+55.28%)
Valor justo
$178
$139–$219
Classificação
Compra forte
confidence 82/100
Potencial de alta
+55.3%
upside to fair value
Margem de segurança
$151.11
MoS level · 15%
Capitalização de mercado
$73.4B
P/E fwd 11.2
Fonte em inglêsPT
Exibindo a fonte em inglês enquanto traduzimos
Este relatório ainda não foi traduzido. Atualize em alguns minutos assim que a fila de tradução recuperar o atraso.

§1 Resumo executivo

  • Composite fair value $178 with high case $219.
  • Implied upside of 55.3% to fair value.
  • Moat 8/10 · confidence 82/100 · Mature compounder.
  • Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$178
Margin of safety
+35.6%
Confidence
82/100
Moat
8/10

Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.

$114.49Price
Low $139.31
Mid $177.78
High $218.83

NTES trades against a final fair-value range of $139.31-$218.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Proprietary IP portfolio with 15+
    Proprietary IP portfolio with 15+ year lifecycle duration
  • Massive R&D scale supporting high-fidelity
    Massive R&D scale supporting high-fidelity production
  • Bull thesis
    Value: Trading at 11.2x fwd P/E vs 20x global peers

§2 Cenário pessimista

A bear-case stress test assuming a 500bps margin compression and 0% terminal growthTerminal growthThe perpetual growth rate assumed in the Gordon-growth terminal-value calculation. Capped below long-run nominal GDP (typically 2.5–3.0% for developed-market firms). resets fair valueFair valueOur composite estimate of intrinsic per-share value, blended across DCF, exit-multiple, and reverse-DCF methods. Reported as a low/mid/high range to capture model uncertainty. to $139.31. Even in this high-pessimism scenario, the massive net cash position ($40B+) provides a structural floor representing 55% of the current market capitalization.

Como esta tese pode falhar

Regulatory Monetization Freeze

15%· Low

China introduces draconian caps on daily spending and loot box mechanics for legacy titles.

FV impact
40% decline
Trigger
6-12 months

Global Pipeline Failure

25%· Medium

High-budget international launches (Where Winds Meet) fail to gain traction, rendering global R&D sunk costs.

FV impact
15% decline
Trigger
18-24 months

Cash Seizure/Restricted Access

10%· Low

Geopolitical escalation leads to restrictions on offshore cash transfers or ADR de-listing.

FV impact
50% decline
Trigger
Immediate
Sinais de alerta antecipado para monitorar
MétricaAtualLimite de gatilho
Sustained quarterly ARPU decline in legacy titlesMonitorDeterioration versus the report thesis
Delay or cancellation of key 2026/27 global releasesMonitorDeterioration versus the report thesis
Reduction or suspension of established buyback programsMonitorDeterioration versus the report thesis
Operating margin compression below 28% thresholdMonitorDeterioration versus the report thesis
Resumption of aggressive regulatory finesMonitorDeterioration versus the report thesis

§3 Histórico financeiro

Demonstração de resultados — últimos seis períodos
ItemT−0T−1T−2T−3CAGR
Período2022-12-312023-12-312024-12-312025-12-31Trend
Receita$96.50B$103.47B$105.30B$112.63B+5.3%
Lucro bruto$52.77B$63.06B$65.81B$72.40B+11.1%
Lucro operacional$19.63B$27.71B$29.58B$35.83B+22.2%
Lucro líquido$20.34B$29.42B$29.70B$33.76B+18.4%
LPA (diluído)$30.85$45.25$45.95$52.40+19.3%
EBITDA$22.49B$30.76B$32.00B$38.08B+19.2%
P&D$15.04B$16.48B$17.52B$17.72B+5.6%
SG&A$18.10B$18.87B$18.70B$18.85B+1.4%

Pontuações de qualidade

OCF / Lucro líquido
1.5×
>1 indica alta qualidade dos lucros
Limite de qualidade contábil
Fail
Limite ajustado ao setor
ROIC
17.0%
Retorno sobre o capital investido
Seção 3

Numbers analysis

Fluxo de caixa

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

Alocação de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Assinantes individuais — a partir do §411 seções a mais

Leia a análise completa — 11 seções a mais.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Relatório completo para cada ticker coberto
24 meses de arquivo de classificações
Briefings da lista de acompanhamento + alertas de mudança de classificação
Exportação PDF + DOCX em qualquer idioma
Iniciar teste grátis
Cancele a qualquer momento.
FAQ

NTES — frequently asked questions

  1. Based on our latest analysis, NTES looks meaningfully undervalued. The current price is $114 versus a composite fair-value midpoint of $178 (range $139–$219), which implies roughly 55.3% upside to the midpoint.
Related coverage

Names readers of NTES also follow

Same archetype: mature-compounder